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Acute epigastric pain is commonly encountered among young adults undergoing military training. Gastric malignancy
usually affects older individuals and may occasionally masquerade as peptic disease. We report a case of primary
gastric lymphoma (PGL) in a young soldier, presenting as an acute upper gastrointestinal tract bleeding. The
case is presented along with a review of the relevant literature. Primary care physicians should bear in mind that
although highly unusual in this age group, primary gastric lymphoma may occasionally afflict young adults and
military recruits as demonstrated by the case under discussion. Nevertheless, referral for investigation of suspected
peptic disease should follow standard guidelines.
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Acute epigastric pain is commonly encountered among
young adults undergoing military training. Gastritis, pep-
tic disease (gastric or duodenal ulcers), gastroesophageal
reflux disease, drug adverse effects and functional
dyspepsia are all common causes for epigastric pain in
this age group. Gastric malignancy usually affects older
individuals and may occasionally masquerade as peptic
disease. We report a case of primary gastric lymphoma
(PGL) in a young soldier, presenting as an acute upper
gastrointestinal tract bleeding. The case is presented
along with a review of the relevant literature.Case presentation
An 18-year-old male soldier was referred to a basic
training clinic for evaluation of an epigastric pain. The
soldier underwent a standard medical evaluation several
months prior to recruitment which was unremarkable.
In the office, the soldier reported having been treated
several weeks pre-recruitment with a standard eradica-
tion regimen for presumed H. pylori infection diagnosed
by both serology and urease breath test. Endoscopy was
not performed.* Correspondence: jacob.moran.gilad@gmail.com
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unless otherwise stated.The soldier reported a constant, stabbing, non-radiating
epigastric pain accompanied by nausea. No aggravating or
alleviating factors were identified. He denied having fever,
vomiting, diarrhea, bloody stools, melena or weight loss.
Upon physical examination, left epigastric tenderness was
noticed on abdominal palpation. The rest of the examin-
ation was unremarkable. The soldier was prescribed oral
H2 blockers with a working diagnosis of peptic disease and
was referred to a gastroenterologist for further evaluation.
Three days later, the soldier was urgently referred back
to the clinic due to a worsened abdominal pain, and
marked fatigue. Physical examination revealed a heart
rate of 120/min, blood pressure 120/75 mmHg and oral
temperature of 37°c. Abdominal examination revealed
only mild epigastric tenderness. During observation,
hypotension which responded to volume expansion was
evident and the patient was thus urgently evacuated to
the nearest hospital.
Upon hospital admission gastric contents resembling
‘Coffee Ground’ were identified following nasogastric
intubation and a rectal examination revealed typical
melena. Laboratory tests revealed severe acute blood
loss with a hemoglobin of 4.5 gr%, hematocrit 14%,
normocytic red blood cell indices, mild leukocytosis
and notable thrombocytosis. Reticulocytosis was noted on
peripheral blood smear. Emergency gastroscopy revealed a
large ulcerated gastric mass in the gastric antrum which. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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without a need for any additional intervention.
Histopathological examination revealed a B-cell lymph-
oma; tumor cells were large and positive for LCA, CD20,
CD79a with Ki67+ (95-100%), consistent with an aggressive
diffuse large B-cell lymphoma, with very high proliferation
index and apoptosis (Figure 1). Abdominal computed tom-
ography demonstrated marked concentric thickening of
gastric antrum with luminal narrowing. The liver was
homogenous and no lymphatic involvement was observed
(Figure 2). No evidence for thoracic involvement was noted
on chest CT. Primary gastric diffuse large B-cell lymphoma
(PG-DLBCL) stage IE was thus diagnosed. Bone marrow
biopsy revealed no infiltration.
Following standard protocols for pre-medication, cardiac
evaluation and sperm cryopreservation, chemotherapy
consisting of intravenous rituximab (8 cycles) in com-
bination with CHOP (6 cycles) was initiated. Adjuvant
pegylated G-CSF was administered following each cycle and
no significant complications were noted. PET-CT evalu-
ation after 4 R-CHOP cycles revealed complete resolution
of the gastric lymphoma mass without any FDG uptake. A
repeated PET-CT after conclusion of chemotherapy showed
normal anatomy without any FDG uptake or evidence for
active lymphoma. The patient was relieved from military
duty and volunteered to service 6 month later upon remis-
sion. The patient is in complete remission over 2.5 years of
follow-up.
Conclusions
Primary gastric diffuse large B-cell lymphoma (PG-DLBCL)
is a part of a larger group termed primary extra-nodal non-Figure 1 Histopathological findings. H&E staining of the gastric biopsy r
a diffuse infiltrate of neoplastic B cells (1b) histopathological findings fromHodgkin’s lymphomas (PE-NHL). The term PE-NHL refers
to lymphomas which present with disease at any organ or
tissue other than the lymph nodes or the spleen; the symp-
toms at initial presentation are caused mainly by extra-
nodal involvement and after routine staging procedures, the
extra-nodal involvement remains the clinically dominant
site of the disease.
PE-NHL comprise ∼ 25–40% of NHL, while primary
NHL of the gastrointestinal tract is the most commonly
involved extra-nodal site and represents 10–15% of all
NHL cases and 30–40% of all extra-nodal sites. The
most commonly involved site is the stomach (60–75% of
cases), followed by the small bowel, ileum, cecum, colon
and rectum [1]. All histological categories of nodal
lymphomas may arise in the gastrointestinal (GI),
but the main two histological subtypes accounting
for over 90% of cases are mucosa-associated lymph-
oid tissue (MALT) NHL and diffuse large B-cell
(DLBCL) NHL.
The diagnosis of primary gastric lymphoma relies on
esophagogastroduodenoscopy and biopsy, followed by
further testing and imaging for staging purposes, including
computed tomography, endoscopic ultrasonography, posi-
tron emission tomography and bone marrow examination
[2]. The treatment of choice for DLBCL irrespective of ana-
tomic site is rituximab combined with an anthracycline-
based combination chemotherapy. The role of surgery in
the management of PG-DLBCL, particularly gastrectomy,
is highly controversial. Radiotherapy may reduce the inci-
dence of relapse but does not affect overall survival. With
adequate treatment, prognosis is good, with a 5-year overall
survival of nearly 90%.evealed a large cell lymphoma infiltrate (1a). CD20 staining highlights
gastric biopsy.
Figure 2 Findings in abdominal computed tomography
consisting of a gastric mass.
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6th decades of life. In one study, the mean age was 57.7 years
[3] while the median age was even higher in another [2].
There is a slight male preponderance [2]. Cases among
individuals prior to the second decade of life are unusual.
According to the IDF recruits database, only 2 cases of
gastric malignancies were reported during the last 5 years,
one of them was MALT NHL, the other being a carcinoma.
The clinical presentation of PG-DLCBL is non-specific.
The initial symptoms of upper abdominal pain and early
satiety may be vague and nonspecific. Other common
symptoms include weight loss, nausea, vomiting, abdom-
inal fullness and indigestion. Symptoms and signs may
mimic those of other abdominal pathologies which are
prevalent among young adults, including infectious gastro-
enteritis, functional dyspepsia, gall bladder disease, and
peptic ulcer disease. Weakness, night sweats, jaundice,
fever and dysphagia occur less frequently. Young adults,
and especially soldiers, in whom there is a low index of
suspicion for gastric malignancy may suffer a delayed
diagnosis. Dietary changes, low hygiene conditions and
physical and emotional stress in the military setting could
further complicate the diagnosis.
Occasional patients present with covert bleeding (as in
our patient), or in the form of frank hematemesis or
melena, while gastric obstruction and perforation are less
common. Uncommon complications include gastrocolic
fistula, gastrointestinal and intra-abdominal hemorrhage
resulting from invasion of a primary gastric lymphoma
into the spleen [4]. In a series of low and high-grade
primary gastric lymphomas the rate of GI bleeding as
a presenting symptom was 15.8% [3]. In another series,
hematemesis and melena were reported among 13.6% and
12.9% of patients with low- and high-grade gastric lymph-
oma respectively. Notably, gastrointenstinal bleeding com-
prised 32% of ‘alarm signs’ reported [5].
The approach to dyspepsia in the young adult age
group (<50 years) involves an investigation of commoncauses such as gastritis, peptic disease (gastric or duodenal
ulcers), gastroesophageal reflux disease, drug adverse
effects and functional dyspepsia. Uncommon causes may
include neoplasms and cardiovascular conditions. In the
absence of ‘red flags’ such as unexplained weight loss,
recurrent vomiting, progressive dysphagia, odynophagia,
gastrointestinal blood loss or family history of upper GI
cancer the common disorders listed above should be
investigated [6]. These should include discontinuation of
medications known to cause dyspepsia. Predominant
reflux symptoms warrant a therapeutic trial with proton
pump inhibitors while predominant dyspepsia without
reflux warrants a work up for H. pylori and appropriate
therapy based on the results. Endoscopic studies are
usually reserved for cases refractory to standard therapy
with proton-pump inhibitors and/or antimicrobial agents
or for those with unexplained etiology or ‘red flags’.
Primary care physicians should bear in mind that
although highly unusual in this age group, malignant
neoplasm may occasionally afflict young adults and
military recruits as demonstrated by the case under
discussion and prompt referral for investigation may
prevent further delays in diagnosis. Nevertheless, referral
for investigation of suspected peptic disease should usually
follow standard guidelines.
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